The Australian Therapeutic Goods Administration (TGA), the regulatory body responsible for therapeutic product oversight, has initiated legal proceedings against News Life Media, Mamamia.com.au, AG Therapeutics, and Straight Up PR. The legal action concerns alleged improper promotion of medical cannabis, which falls under the stringent guidelines of the Therapeutic Goods Act of 1989. This law prohibits direct-to-public advertising of prescription medicines without TGA approval.
TGA officials have alleged repeated warnings issued to the companies involved, citing violations such as promotional messaging that characterizes cannabis as “plant medicine” and unauthorized online campaigns encouraging cannabis use.
Australia maintains a federally legalized medical cannabis program under strict regulations, but recreational cannabis remains illegal. The Australian Medical Association supports certain decriminalization efforts but remains opposed to full adult-use legalization.
Despite regulatory challenges, the Australian legal cannabis market is poised for significant growth. Recent market research forecasts a surge from approximately USD 126 million in 2024 to over USD 420 million by 2030.
What This Means for Cannabis Businesses and Insurers?
Cannas Capital understands the complex regulatory landscape that cannabis businesses operate in worldwide. Our specialized insurance products are designed to protect cannabis companies against risks arising from evolving regulations, advertising compliance, and operational challenges. As markets grow and regulations tighten, partnering with an InsurTech leader like Cannas Capital ensures your business is covered against emerging liabilities.
We continue to track global regulatory trends to help clients navigate risk proactively. Whether you are operating in Australia, the U.S., or emerging cannabis markets worldwide, our tailored insurance solutions and expert guidance provide peace of mind in an ever-changing environment.
Stay Compliant, Stay Protected
For cannabis businesses, advertising compliance is not just a legal obligation but a critical component of brand reputation and operational security. Cannas Capital’s insurance policies also include risk management services to support regulatory adherence and minimize exposure to fines or lawsuits related to marketing practices.
Cannas Capital is closely monitoring regulatory developments in global cannabis markets, including recent legal action taken by Australian authorities against several media companies for allegedly violating strict advertising laws related to cannabis products.
Are you 18 or older?The law requires you to be 18 years of age or older to enter this website. Please verify your age to view the content, or click "Exit" to leave.
